ALESSANDRI, Amedea Caterina
ALESSANDRI, Amedea Caterina
Himpact of liver steatosis on the antiviral response in the hepatitis C virus –associated chronic hepatitis.
2006-01-01 SORESI, M; TRIPI, S; FRANCO, V; GIANNITRAPANI, L; ALESSANDRI, A; RAPPA, A; VUTURO, O; MONTALTO, G
Impact of liver steatosis on the antiviral response in the hepatitis C virus-associated chronic hepatitis.
2006-01-01 SORESI M; TRIPI S; FRANCO V; GIANNITRAPANI L; ALESSANDRI A; RAPPA F; VUTURO O; MONTALTO G
L’esposizione professionale in ambiente sanitario: attuali dati sulla valutazione e prevenzione del rischio
2003-01-01 TORREGROSSA, MV; ALESSANDRI, AC; TRIPI, S
PREVALENZA ED INCIDENZA DELLE EPATITI CRONICHE IN DIFFERENTI POPOLAZIONI DELLA SICILIA OCCIDENTALE
2011-04-11 Alessandri, .
Reliability of the bright liver echo pattern in diagnosing steatosis in patients with cryptogenic and HCV-related hypertransaminasaemia.
2009-01-01 Soresi, M; Giannitrapani, L; Florena, AM; La Spada, E; Di Gesaro, V; Rappa, F; Alessandri, AC; Tripi, S; Romano, M; Montalto, G
Retreatment of interferon plus ribavirin unresponsive patients with chronic hepatitis C with peginterferon alfa 2a plus mycofenolatemofetile or peginterferon alfa 2 a plus ribavirin
2005-01-01 TRIPI S; DI GAETANO G; ALESSANDRI A; VUTURO O; SORESI M; SPADARO A; FRENI M; BRUNO S; SICILIANO R; MONTALTO G
Safety and efficacy of Peginterferon (PEG-IFN) alpha 2 a(40 Kda) plus mycofenolatemofetile (MMF) and Peginterferon alpha 2 a plus Ribavirin (RBV) in unresponsive patients with chronic C hepatitis (CHC).
2005-01-01 TRIPI S; DI GAETANO G; ALESSANDRI A; VUTURO O; SORESI M; SPADARO A; FRENI M; BRUNO S; SICILIANO R; MONTALTO G
safety and efficacy of peginterferon (PEG-IFN) alpha 2a plus mycofenolatemoftile and peginterfron alpha 2a plus ribavirin in unresponsive patients with chronic C hepatitis
2005-01-01 TRIPI S; DI GAETANO G; ALESSANDRI A; VUTURO O; SORESI M; SPADARO A; FRENI M; BRUNO S; SICILIANO R; MONTALTO G
Safety and efficacy of peginterferon alpha 2a plus mycofenolatemofetile and peginterferon alpha 2a plus Ribavirin in unresponsive patients with chronic hepatitis C
2005-01-01 S TRIPI; G DI GAETANO; A ALESSANDRI; O VUTURO; M SORESI; A SPADARO; M FRENI; S BRUNO; R SICILIANO; MONTALTO G
Studio sulla frequenza dei genotipi virali e loro risposta terapeutica su un gruppo di soggetti ex drug dipendents con epatite cronica HCV-correlata.
2006-01-01 TRAINA S; TRIPI S; GIAMBRA D; TOMASELLIG; ALESSANDRI A; BALDANZA R; PARRINO A; MONTALTO G
The treatment of chronic hepatitis C: role of ICAM-1 and response to interferon
2008-01-01 TRIPI S; DI GAETANO G; ALESSANDRI A; MANCUSO G